Protein levels of neurofilament subunits in the hen central nervous system following prevention and potentiation of diisopropyl phosphorofluoridate (DFP)-induced delayed neurotoxicity

Biochemical Pharmacology

Volumn 63, Issue 1, 2002, Pages 11-19

  Xie, Keqin ^a   Gupta, Ram P ^b   Abou Donia, Mohamed B ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cerebrum; Chickens; DFP; NF H; NF L; NF M; OPIDN; PMSF; Spinal cord

Indexed keywords

BENZYLSULFONYL FLUORIDE; BRAIN PROTEIN; DYFLOS; NEUROFILAMENT PROTEIN; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DELAYED NEUROTOXICITY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; HEN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

ANIMALS; CHICKENS; DRUG INTERACTIONS; ISOFLUROPHATE; NEUROFILAMENT PROTEINS; NEUROTOXICITY SYNDROMES; PHENYLMETHYLSULFONYL FLUORIDE; PROTEASE INHIBITORS; SPINAL CORD; TELENCEPHALON;

EID: 0036147696     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00858-9     Document Type: Article

References (30)

1. Organophosphorus ester-induced delayed neurotoxicity
2. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and Type II
3. Organophosphorus pesticides
4. The ultrastructure of tri-ortho-cresyl phosphate poisoning. I. Studies on myelin and axonal alterations in the sciatic nerve
5. Ultrastructure of tri-ortho-cresyl phosphate poisoning in the chicken. II. Studies on spinal cord alterations
6. The time course of protection from delayed neurotoxicity induced by tri-o-cresyl phosphate and O,O-diisopropyl phosphorofluoridate by phenyl methyl sulfonyl fluoride in chickens
7. Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: Distribution of axonal lesions
8. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride
9. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethylsulfonyl fluoride
10. Gene targeting studies begin to reveal the function of neurofilament proteins
11. Neurofilament functions in health and disease
12. Transient expression of the neurofilament proteins NF-L and NF-M by Schwann cells is regulated by axonal contact
13. Rapid movement of axonal neurofilaments interrupted by prolonged pauses
14. Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit
15. Antagonistic roles of neurofilament subunits NF-H and NF-M against NF-L in shaping dendritic arborization in spinal motor neurons
16. Alterations of intermediate filaments in various histopathological conditions
17. Neurofilaments in health and disease
18. Comparison of changes in β-tubulin and NF gene expression in rat DRG neurons under regeneration-permissive and regeneration-prohibitive conditions
19. Dose-dependent selective suppression of light (NFL) and medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity
20. Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate (DFP)-treated hen spinal cord and their presence in axonal aggregations
21. Neurofilament protein heterotetramers as assembly intermediates
22. Heterodimeric associations between neuronal intermediate filament proteins
23. Enhanced calmodulin binding concurrent with increased kinase-dependent phosphorylation of cytoskeletal proteins following a single subcutaneous injection of diisopropyl phosphorofluoridate in hens
24. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
25. Effect of prevention and potentiation of diisopropyl phosphorofluoridate (DFP)-induced delayed neurotoxicity on the mRNA expression of neurofilament subunits in hen central nervous system
26. Neuronal intermediate filaments
27. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter
28. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy
29. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN)
30. Pathogenesis of two axonopathies does not require axonal neurofilaments